Intratracheal Budesonide With Surfactant to Prevent Bronchopulmmonary Dysplasia.

NCT04862377 · clinicaltrials.gov ↗

PHASE3

Phase

UNKNOWN

Status

50

Enrollment

OTHER

Sponsor class

Conditions

Bronchopulmonary Dysplasia
Respiratory Distress Syndrome in Premature Infant
Prematurity

Interventions

DRUG: Poractant Alfa Intratracheal Suspension [Curosurf]
DRUG: Budesonide 0.5 MG/ML

Sponsor

Hospital Clinic of Barcelona